Literature DB >> 28134052

Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort.

Laura Sánchez-Iñigo1,2,3, David Navarro-González1,3, Alejandro Fernández-Montero3,4,5, Juan Pastrana-Delgado3,6,7, J A Martínez3,7,8,9.   

Abstract

Background Whether obesity is a major risk factor for cardiovascular disease in the absence of metabolic comorbidities remains under debate. Indeed, some obese individuals may be at low risk of metabolic-related complications, while normal-weight individuals may not be "healthy." Aims To assess the incidence of ischemic stroke according to the metabolic health and obesity states of 5171 participants from the Vascular-Metabolic CUN cohort. Methods A Cox proportional-hazard analysis was conducted to estimate the hazard ratio and their 95% confidence interval of stroke according to the metabolic health and obesity states based on TyG index and Adult Treatment Panel-III criteria, during 9.1 years of follow-up. Results After 50,056.2 person-years of follow-up, 162 subjects developed an ischemic stroke (incidence rate 3.23 per 1000 person-years). Metabolically healthy obese subjects did not show greater risk of stroke, while metabolically unhealthy participants, obese and non-obese, had an increased risk of stroke, compared with healthy non-obese. The hazard ratios for the multivariable adjusted model were 1.55 (95% CI: 1.36-1.77) and 1.86 (95% CI: 1.57-2.21), respectively. Conclusions Metabolically unhealthy individuals exhibited a greater risk of ischemic stroke than metabolically healthy obese individuals.

Entities:  

Keywords:  Obesity; cerebrovascular disease; hypertriglyceridemia; insulin resistance; ischemic stroke; metabolic syndrome

Mesh:

Year:  2016        PMID: 28134052     DOI: 10.1177/1747493016672083

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  19 in total

1.  The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Kurosh Djafarian; Hadis Mozafari; Sakineh Shab-Bidar
Journal:  Endocrine       Date:  2019-01-22       Impact factor: 3.633

2.  Ph- myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide.

Authors:  Milan Košťál; Jiří Schwarz; Petra Ovesná; Miroslav Penka; Petr Dulíček
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

3.  Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care.

Authors:  Alessandra da Silva; Ana Paula Silva Caldas; Helen Hermana Miranda Hermsdorff; Ângela Cristine Bersch-Ferreira; Camila Ragne Torreglosa; Bernardete Weber; Josefina Bressan
Journal:  Cardiovasc Diabetol       Date:  2019-07-11       Impact factor: 9.951

4.  High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.

Authors:  Erfei Luo; Dong Wang; Gaoliang Yan; Yong Qiao; Bo Liu; Jiantong Hou; Chengchun Tang
Journal:  Cardiovasc Diabetol       Date:  2019-11-13       Impact factor: 9.951

5.  Associations between Triglyceride-Glucose Index and Micro- and Macro-angiopathies in Type 2 Diabetes Mellitus.

Authors:  Hsuan Chiu; Hui-Ju Tsai; Jiun-Chi Huang; Pei-Yu Wu; Wei-Hao Hsu; Mei-Yueh Lee; Szu-Chia Chen
Journal:  Nutrients       Date:  2020-01-26       Impact factor: 5.717

Review 6.  Metabolically Healthy Obesity-Heterogeneity in Definitions and Unconventional Factors.

Authors:  Inês Brandão; Maria João Martins; Rosário Monteiro
Journal:  Metabolites       Date:  2020-01-27

7.  Retrospective Study Using Computed Tomography to Compare Sufficient Chest Compression Depth for Cardiopulmonary Resuscitation in Obese Patients.

Authors:  Heekyung Lee; Jaehoon Oh; Juncheol Lee; Hyunggoo Kang; Tae Ho Lim; Byuk Sung Ko; Yongil Cho; Soon Young Song
Journal:  J Am Heart Assoc       Date:  2019-11-26       Impact factor: 5.501

8.  Risk of ischemic stroke in metabolically healthy obesity: A nationwide population-based study.

Authors:  Hyun-Jung Lee; Eue-Keun Choi; Seung-Hwan Lee; Yong-Jin Kim; Kyung-Do Han; Seil Oh
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

9.  Metabolic syndrome and risk of stroke: Protocol for an update systematic review and meta-analysis.

Authors:  Leonardo Roever; Elmiro Santos Resende; Angélica Lemos Debs Diniz; Nilson Penha-Silva; João Lucas O'Connell; Paulo Fernando Silva Gomes; Hugo Ribeiro Zanetti; Anaisa Silva Roerver-Borges; Fernando César Veloso; Thiago Montes Fidale; Antonio Casella-Filho; Paulo Magno Martins Dourado; Antonio Carlos Palandri Chagas; Sadeq Ali-Hasan-Al-Saegh; Paulo Eduardo Ocke Reis; Rogério de Melo Pinto; Gustavo B F Oliveira; Álvaro Avezum; Mansueto Neto; André Durães; Rose Mary Ferreira Lisboa da Silva; Antonio José Grande; Celise Denardi; Renato Delascio Lopes; Nitesh Nerlekar; Shahab Alizadeh; Adrian V Hernandez; Giuseppe Biondi-Zoccai
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

10.  High-density lipoprotein-cholesterol functionality and metabolic syndrome: Protocol for review and meta-analysis.

Authors:  Leonardo Roever; Elmiro Santos Resende; Angélica Lemos Debs Diniz; Nilson Penha-Silva; João Lucas O'Connell; Paulo Fernando Silva Gomes; Hugo Ribeiro Zanetti; Anaisa Silva Roerver-Borges; Fernando César Veloso; Fernanda Rodrigues de Souza; Poliana Rodrigues Alves Duarte; Thiago Montes Fidale; Antonio Casella-Filho; Paulo Magno Martins Dourado; Antonio Carlos Palandri Chagas; Sadeq Ali-Hasan-Al-Saegh; Paulo Eduardo Ocke Reis; Rogério de Melo Costa Pinto; Gustavo B F Oliveira; Álvaro Avezum; Mansueto Neto; André Rodrigues Durães; Rose Mary Ferreira Lisboa da Silva; Antonio José Grande; Celise Denardi; Renato Delascio Lopes; Nitesh Nerlekar; Shahab Alizadeh; Adrian V Hernandez; Maria Inês da Rosa; Giuseppe Biondi-Zoccai
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.